InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Lalwani Nikhil, Chairman & CEO. Officer active across 1 companies, notably ANI Pharmaceuticals INC. In total, 6 disclosures have been recorded. Total volume traded: €181k. The latest transaction was disclosed on 27 April 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
033,352 shares0
Common Stock
SEC:0001415889-22-004403:0·
0100,055 shares0
Common Stock
SEC:0001415889-22-003392:0·
€427,73617,454 shares@ €24.50650.024% mcap58.4% of flow
Common Stock
SEC:0001415889-22-003380:0·
€181,1057,224 shares@ €25.070.010% mcap24.7% of flow
Common Stock
SEC:0001415889-22-003308:0·
Ideal exit: 16 Dec 2022 (T+270)
€61,4862,577 shares@ €23.85970.0035% mcap100.0% of flow
Common Stock
SEC:0001415889-21-004348·
€61,4862,577 shares@ €23.85970.0035% mcap8.4% of flow
Common Stock
SEC:0001415889-21-004348:0·
6 of 6 declarations
About Lalwani Nikhil
Nikhil Lalwani is the President and Chief Executive Officer of ANI PHARMACEUTICALS INC. He leads the company with a strategic vision, focusing on innovation and the expansion of pharmaceutical products. With a strong background in the industry, he is committed to improving the company's outcomes while addressing the needs of patients and healthcare professionals.
